Table 1.
Summary of National Institute for Health and Care Excellence guidelines4
| > Consider DXA in patients starting treatments that may affect bone density (eg goserelin for prostate cancer). |
| > Do not assess fracture risk routinely in people aged <50 years unless they have major risk factors. |
| > Consider assessment in women aged <65 years and men aged <75 years in the presence of risk factors (eg prior fragility fracture, current smoker, low BMI). |
| > Consider assessment in all women aged >65 years and all men aged >75 years. |
DXA = dual energy x-ray absorptiometry; BMI = body mass index